A detailed history of Qube Research & Technologies LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 164,803 shares of MRNA stock, worth $10.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
164,803
Previous 28,500 478.26%
Holding current value
$10.8 Million
Previous $3.04 Million 544.6%
% of portfolio
0.03%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $15.2 Million - $25 Million
150,261 Added 1033.29%
164,803 $19.6 Million
Q1 2024

May 14, 2024

BUY
$85.37 - $115.44 $1.24 Million - $1.68 Million
14,542 New
14,542 $1.55 Million
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $16.1 Million - $23.4 Million
-118,873 Reduced 56.67%
90,885 $14 Million
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $24.8 Million - $44.1 Million
209,758 New
209,758 $37.7 Million
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $16 Million - $24.2 Million
137,017 New
137,017 $19.6 Million
Q1 2022

May 09, 2022

SELL
$126.46 - $235.05 $5.73 Million - $10.6 Million
-45,298 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$225.82 - $368.51 $5.03 Million - $8.22 Million
22,293 Added 96.91%
45,298 $11.5 Million
Q3 2021

Nov 12, 2021

SELL
$221.9 - $484.47 $4.55 Million - $9.93 Million
-20,504 Reduced 47.13%
23,005 $8.85 Million
Q2 2021

Aug 13, 2021

BUY
$129.91 - $234.98 $5.65 Million - $10.2 Million
43,509 New
43,509 $10.2 Million
Q1 2021

May 14, 2021

SELL
$109.18 - $185.98 $35 Million - $59.7 Million
-320,820 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$65.74 - $169.86 $21.1 Million - $54.5 Million
320,820 New
320,820 $33.5 Million
Q2 2020

Aug 14, 2020

SELL
$29.67 - $80.0 $1.05 Million - $2.82 Million
-35,280 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$17.78 - $31.58 $627,278 - $1.11 Million
35,280 New
35,280 $1.06 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.